30
Views
0
CrossRef citations to date
0
Altmetric
Research Article

Long-term culture of hematopoietic stem cells - validating the stromal component of the CAFC assay

, , &
Pages 107-116 | Published online: 07 Jul 2009

References

  • Ouesenberry PJ. Hematopoietic stem cells, progenitor cells, and cytokines. In: Beutler E, Lichtman MA, CoIler BS et al. Williams Hematology, 5th edn.;McGraw-Hill, Inc.: USA, 1995.
  • Verfaille C, Ploemacher R, Di Persio J et al. Assays to deter-mine hematopoietic stem cell content in blood or marrow grafts. Cytotherapy 1999;1:41–9.
  • Krause DS, Fackler MJ, Civin CI et al. CD34: structure, biol-ogy, and clinical utility. Blood 1996;87:1–13.
  • Sutherland DR, Anderson L, Keeney M et al. The ISHAGEguidelines for CD 34+ cell determination by flow cytometry. International Society of Hematotherapy and Graft Engineering. 7 Hematother 1996;5:213–26.
  • Spangrude GJ, Brooks DM, Tumas DB. Long-term repopu-lation of irradiated mice with limiting numbers of purified hematopoietic stem cells: in vivo expansion of stem cell phenotype but not function. Blood 1995;85:1006–16.
  • Osawa M, Hanada K, Hamada H et al. Long-term lympho-hematopoietic reconstitution by a single CD34 — low/negative hematopoietic stem cell. Science 1996;273: 242–5.
  • Bhatia M, Bonnet D, Murdoch B et al. A newly discoveredclass of human hematopoietic cells with SCID— repopulat-ing activity. Nat Med 1998;4:1038–45.
  • Dexter TM, Allen TD, Lajtha LG. Conditions controlling the proliferation of haemopoietic stem cells in vitro. 7 Cell Physiol 1976;91: 335–44.
  • Gartner S, Kaplan HS. Long-term culture of human bonemarrow cells. Proc Natl Acad Sci USA 1980;77:4756–9.
  • Hao Q_L, Thiemann FT, Petersen D et al. Extended long-term culture reveals a highly quiescent and primitive human hematopoietic progenitor population. Blood 1996;88: 3306–13.
  • Bender JG, To LB, Williams S et al. Defining a therapeutic dose of peripheral blood stem cells. 7 Hematother 1992;1:329–41.
  • Lumley MA, Burton A, Billingham LJ et al. Quality assur-ance of CFU-GM assays: inter-laboratory variation despite standard reagents. EurY Haematol 1999;62:32–7.
  • Breems DA, Blokland EA, Neben S et al. Frequency analysis of human primitive haematopoietic stem cell subsets using a cobblestone area forming cell assay. Leukemia 1994;8: 1095–104.
  • Wineman J, Moore K, Lemischka I et al. Functional hetero-geneity of the hematopoietic microenvironment: rare stromal elements maintain long-term repopulating stem cells. Blood 1996;87:4082–90.
  • Hogge DE, Lansdorp PM, Reid D et al. Enhanced detection, maintenance, and differentiation of primitive human hematopoietic cells in cultures containing murine fibro-blasts engineered to produce human steel factor, interleukin-3, and granulocyte colony-stimulating factor. Blood 1996;88:3765–73.
  • Weaver A, Ryder WD, Testa NG et al. Measurement of long-term culture initiating cells (LTC-ICs) using limiting dilution: comparison of endpoints and stromal support. Exp Hematol 1997;25:1333–8.
  • Yao M, Bouchet S, Harnois C et al. Quantitative and qualita-tive alterations of long-term culture-initiating cells in patients with acute leukaemia in complete remission. Br Haematol 1998;103:129–8.
  • Sutherland HJ, Lansdorp PM, Henkelman DH et al. Functional characterization of individual human hematopoietic stem cells cultured at limiting dilution on supportive marrow stromal layers. Proc Natl Acad Sci USA 1990;87:3589–8.
  • Ploemacher RE, van der Sluijs JP, Voerman JS et al. An in vitro limiting-dilution assay of long-term repopulating hematopoietic stem cells in the mouse. Blood 1989;74:2755–63.
  • Pettengell R, Luft T, Henschler R et al. Direct comparison by limiting dilution analysis of long-term culture-initiating cells in human bone marrow, umbilical cord blood, and blood stem cells. Blood 1994;84:3653–9.
  • Carlo-Stella C, Tabilio A, Regazzi E et al. Effect of chemotherapy for acute myelogenous leukemia on hematopoietic and fibroblast marrow progenitors. Bone Marrow Transplant 1997;20:465–71.
  • Soligo DA, Lambertenghi Deliliers G, Servida F et al. Haematopoietic abnormalities after autologous stem cell transplantation in lymphoma patients. Bone Marrow Transplant 1998;21:15–22.
  • Holm M, Thomsen M, Hoyer M et al. Dynamic cell cycle kinetics of normal CD34+ cells and CD38+/— subsets of haemopoietic progenitor cells in G-CSF-mobilized periph-eral blood. Br .7 Haematol1999;105:1002–13.
  • Lemoine FM, Humphries RK, Abraham SD et al. Partial characterization of a novel stromal cell-derived pre-B-cell growth factor active on normal and immortalized pre-B cells. Exp Hematol 1988;16:718–26.
  • Sutherland HJ, Hogge DE, Cook D et al. Alternative mech-anisms with and without steel factor support primitive human hematopoiesis. Blood 1993;81:1465–70.
  • Taswell C. Limiting dilution assays for the determination of immunocompetent cell frequencies. I. Data analysis. immund 1981;126:1614–9.
  • Fazekas de St Groth S. The evaluation of limiting dilution assays. 7 Immunol Methods 1982;49:R11–23.
  • McCullagh P, Nelder JA. Generalized linear models, 2nd edn. Cambridge University Press: Cambridge, 1989.
  • Mazini L, Wunder E, Sovalat H et al. Mature accessory cells influence long-term growth of human hematopoietic prog-enitors on a murine stromal cell feeder layer. Stem Cells 1998;16:404–12.
  • Prosper F, Stroncek D, Verfaillie CM. Phenotypic and func-tional characterization of long-term culture-initiating cells present in peripheral blood progenitor collections of normal donors treated with granulocyte colony-stimulating factor. Blood 1996;88:2033–42.
  • Lemischka IR. Microenvironmental regulation of hematopoietic stem cells. Stem Cells 1997;15(Suppl 1):63–8.
  • Uchida N, Fleming WH, Alpern EJ et al. Heterogeneity of hematopoietic stem cells. Curr Opin Immunol 1993;5:177–84.
  • Weissman IL. Developmental switches in the immune sys-tem. Ce111994;76:207–18.
  • Dick JE. Normal and leukemic human stem cells assayed in SCID mice. Semin Immunol1996;8:197–206.
  • Koller MR, Manchel I, Smith AK. Quantitative long-term culture-initiating cell assays require accessory cell deple-tion that can be achieved by CD 34-enrichmentor 5-fluorouracil exposure. Blood 1998;91: 4056–64.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.